Building on our team’s long-term experience with anticoagulants, antianginal, antihypertensive, and antiplatelet agents, we are able to work with opinion leaders to discuss and educate on a wide range of issues in cardiology. As an example, we recently facilitated advisory boards with the opinion leaders who write the guidelines, as well as those who work in community practice, to develop a series of online presentations covering such topics as:
- Identification and management of high-risk patients
- Assessment of residual cardiovascular risk following statin therapy
- Interventional prevention of heart disease and stroke
- Case-based education in primary and secondary prevention